SUBSCRIBE
SUBSCRIBE
News   Drug Development

Japan’s Eisai Inc. to Delay Parkinson’s Drug Submission

October 30, 2007 | 
1 min read
TOKYO, Oct 30 (Reuters) - Japanese drug maker Eisai Co Ltd (4523.T: Quote, Profile, Research) said on Tuesday it would delay submission of its U.S. and European applications for a drug candidate to treat Parkinson's disease.
Clinical research Phase 3 Asia
MORE ON THIS TOPIC
Close up shot of the dart arrow hit on bulleyes of dartboard to represent that the business reached the target with dark tone picture style. Target and goal as concept.
Diabetes
Lilly Tops Novo in Weight Loss Again, This Time on the Oral Front
February 26, 2026
 · 
2 min read
 · 
Annalee Armstrong
Working man icon pushing the load on the line. Hard work, labor, effort and determination concept.
HIV
Gilead, Merck Clear Path to Market for Daily HIV Pills With New Late-Stage Data
February 26, 2026
 · 
2 min read
 · 
Tristan Manalac
Dollar boat swimming on paper waves
Startups
Harbour Cofunds Cancer Startup, Hands Off Clinical-Stage Antibody
February 25, 2026
 · 
2 min read
 · 
Tristan Manalac
Alarm clock with pause sign, take a break, menopause concept, hormone replacement therapy
Regulatory
Patient Death Forces Partial Freeze on MacroGenics’ Gynecologic Cancer Study
February 25, 2026
 · 
2 min read
 · 
Tristan Manalac